Alto Neuroscience ANRO Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's long-term debt?
- Alto Neuroscience (ANRO) reported long-term debt of $13.89M in Q1 2026.
- How has Alto Neuroscience's long-term debt changed year-over-year?
- Alto Neuroscience's long-term debt decreased by 30.4% year-over-year, from $19.94M to $13.89M.
- What is the long-term trend for Alto Neuroscience's long-term debt?
- Over 2 years (2023 to 2025), Alto Neuroscience's long-term debt has grown at a 28.1% compound annual growth rate (CAGR), from $9.86M to $16.17M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.